Gradientech starts US 510(k) study for QuickMIC® at clinical sites
Following successful pre-clinical evaluation studies of the QuickMIC system in the US last year, and with a breakthrough device designation ...
Read more
Etiket: QuickMIC®
Gradientech and Momentum Bioscience in continued collaboration
Momentum Bioscience is developing the SepsiSTAT® technology allowing isolation and separation of bacteria directly from blood. By combining the enrichment ...
Read more
Promising QuickMIC® data from two US study sites will be presented at ASM Microbe 2024
Organised by the American Society of Microbiology, ASM Microbe is one of the largest microbial sciences conferences in the US, bringing together ...
Read more